Kristin Schneider

Kristin E. Schneider, PhD, is an Associate Research Professor in the Department of Health, Behavior and Society at Johns Hopkins University. Her work focuses on harm reduction strategies to address overdose and infectious disease risks among marginalized populations in both urban and rural settings. She holds a PhD from Johns Hopkins (2019) and a BA from New York University (2013). Dr. Schneider's research emphasizes translational implications for policy and practice, particularly around naloxone programs, syringe services, and overdose prevention initiatives.

Education:

• PhD in Public Health, Johns Hopkins University, 2019
• BA in Psychology, New York University, 2023

Research Interests: Dr. Schneider investigates overdose prevention, harm reduction practices, polysubstance use epidemiology, and social determinants of health. Her work bridges clinical and community-based approaches to address structural vulnerabilities faced by people who use drugs. Recent projects include evaluation of overdose data systems and studies on xylazine contamination in the drug supply.

Key Scientific Contributions: Her 2023 work revealed increased solitary drug use during the pandemic, while 2021 research identified fentanyl's role in overdose fatalities. She has authored over 80 peer-reviewed articles, with a focus on rural health disparities and HIV risk behaviors among injection drug users.

Awards: Recipient of the 2023 Baltimore Public Health Practice Excellence Award for innovative harm reduction strategies.

Professional Activities: Leads the Overdose Data 2 Action initiative and the REFLEX study on xylazine's health impacts. Collaborates with syringe service programs and conducts community-engaged research to inform evidence-based policies.